NON SMALL CELL LUNG CANCER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Type
• Market Snapshot, By Treatment
• Market Snapshot, By End User
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter’s Analysis

4. Global Non-Small Cell Lung Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Non-Small Cell Lung Cancer Market, By Type, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Adenocarcinoma
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Squamous Cell Carcinoma
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Large Cell Carcinoma
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Large Cell Neuroendocrine Tumors
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

6. Global Non-Small Cell Lung Cancer Market, By Treatment, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Chemotherapy  
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Targeted Therapy
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Bevacizumab (Avastin)
•  Necitumumab (Portrazza)
•  Ramucirumab (Cyramza)
• Immunotherapy
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Nivolumab (Opdivo)
•  Atezolizumab (Tecentriq)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

7. Global Non-Small Cell Lung Cancer Market, By End User, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Hospitals
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Home Care
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Specialty Clinics
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

8. Global Non-Small Cell Lung Cancer Market, By Region, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2021–2033
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
• F. Hoffmann-La Roche Ltd.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Honeywell International Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• AstraZeneca PLC
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Merck & Co., Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Pfizer Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Bristol-Myers Squibb Company
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Novartis AG
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Eli Lilly and Company
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Boehringer Ingelheim International GmbH
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Celgene Corporation
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Amgen Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Johnson & Johnson
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Gilead Sciences, Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• AbbVie Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Astellas Pharma Inc.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Takeda Pharmaceutical Company Limited
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Sanofi
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Teva Pharmaceutical Industries Ltd.
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Bayer AG
• Company Highlights
• Method Portfolio
• Key Highlights
• Financial Performance
• Market Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Section

• References
• Research Methodology
• About Us and Sales Contact